E-LIB Suche - Ergebnisse für: Kwara, E.

1

Reference values for commonly used biochemical and haematol..:

Dosoo, D. ; Kwara, E. ; Osei-Kwakye, K....
Clinical Biochemistry. 44 (2011) 7 - p. 529 , 2011

Link: https://doi.org/10.1016/..

2

Pharmacogenetic determinants of tenofovir diphosphate and l..:

Bae, Jihyun ; Tantawy, Marwa ; Gong, Yan...
Antimicrobial Agents and Chemotherapy. , 2024

Link: https://doi.org/10.1128/..

3

Cross-protocol assessment of induction and durability of VI..:

Espy, Nicole ; Han, Xue ; Grant, Shannon...
PLOS Global Public Health. 3 (2023) 6 - p. e0002037 , 2023

Link: https://doi.org/10.1371/..

4

Su1359: CHARACTERIZATION OF HBV PRE-GENOMIC RNA IN AN HBV/H..:

Sherman, Kenneth E. ; Rouster, Susan D. ; Meeds, Heidi L....
Gastroenterology. 162 (2022) 7 - p. S-571 , 2022

Link: https://doi.org/10.1016/..

5

Global estimates and determinants of antituberculosis drug ..:

Gafar, Fajri ; Wasmann, Roeland E. ; McIlleron, Helen M....
European Respiratory Journal. 61 (2022) 3 - p. 2201596 , 2022

Link: https://doi.org/10.1183/..

6

HIV virological non-suppression and its associated factors ..:

Afrane, Adwoa K. A. ; Goka, Bamenla Q. ; Renner, Lorna...
BMC Infectious Diseases. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

7

In response to identification of a quadruple mutation that ..:

Blackard, Jason T. ; Kwara, Awewura ; Sherman, Kenneth E.
Journal of Hepatology. 71 (2019) 6 - p. 1259-1260 , 2019

Link: https://doi.org/10.1016/..

8

Low Birthweight, Retention in HIV Care, and Adherence to AR..:

Sakyi, Kwame S. ; Lartey, Margaret Y. ; Dension, Julie A....
AIDS and Behavior. 23 (2018) 2 - p. 433-444 , 2018

Link: https://doi.org/10.1007/..

9

Sex differences in perceived risk and testing experience of..:

Yawson, Alfred E ; Appiah, Labi K ; Yawson, Anita O...
International Journal for Equity in Health. 13 (2014) 1 - p. , 2014

Link: https://doi.org/10.1186/..

10

Viral Decay Rates are Similar in HIV-infected Patients with..:

Lartey, M. ; Sagoe, K. W. ; Yang, H....
Clinical Infectious Diseases. 52 (2011) 4 - p. 547-550 , 2011

Link: https://doi.org/10.1093/..

11

Global estimates and determinants of antituberculosis drug ..:

Gafar, Fajri ; Wasmann, Roeland E ; McIlleron, Helen M...
https://research.rug.nl/en/publications/ddfd6b5b-4784-40f3-86b2-e974e0dea717. , 2023

Link: https://hdl.handle.net/1..

12

Global estimates and determinants of antituberculosis drug ..:

Gafar, Fajri ; Wasmann, Roeland E ; McIlleron, Helen M...
European Respiratory Journal, 0903-1936, 2023, 61:3,. , 2023

Link: http://urn.kb.se/resolve..

13

Global estimates and determinants of antituberculosis drug ..:

Gafar, Fajri ; Wasmann, Roeland E ; McIlleron, Helen M...
https://discovery.ucl.ac.uk/id/eprint/10159960/2/Choo_R1.ERJ%20Gafar%20et%20al.%20IPDMA%20-%20main%20manuscript.pdf. , 2023

Link: https://discovery.ucl.ac..

14

Cross-protocol assessment of induction and durability of VI..:

Espy, Nicole ; Han, Xue ; Grant, Shannon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249892/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Global estimates and determinants of antituberculosis drug ..:

Gafar, Fajri ; Wasmann, Roeland E ; McIlleron, Helen M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996834/. , 2023

Link: http://www.ncbi.nlm.nih...